These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8895490)

  • 1. p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons.
    Kazachkov Y; Khaoustov V; Yoffe B; Solomon H; Klintmalm GB; Tabor E
    Carcinogenesis; 1996 Oct; 17(10):2207-12. PubMed ID: 8895490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.
    Goldblum JR; Bartos RE; Carr KA; Frank TS
    Am J Surg Pathol; 1993 Dec; 17(12):1244-51. PubMed ID: 8238731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma.
    Diamantis ID; McGandy C; Chen TJ; Liaw YF; Gudat F; Bianchi L
    J Hepatol; 1994 Apr; 20(4):553-6. PubMed ID: 8051396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.
    Rivkina MB; Cullen JM; Robinson WS; Marion PL
    Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.
    Shi CY; Phang TW; Lin Y; Wee A; Li B; Lee HP; Ong CN
    Br J Cancer; 1995 Jul; 72(1):146-9. PubMed ID: 7599044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.
    Hsia CC; Nakashima Y; Thorgeirsson SS; Harris CC; Minemura M; Momosaki S; Wang NJ; Tabor E
    Oncol Rep; 2000; 7(2):353-6. PubMed ID: 10671685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
    Shi CY; Phang TW; Wee A; Ngoi SS; Lin Y; Li B; Ong CN; Lee HP
    Ann Acad Med Singap; 1995 Mar; 24(2):204-10. PubMed ID: 7653961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
    Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
    Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.
    Lee SN; Park CK; Sung CO; Choi JS; Oh YL; Cho JW; Yoo BC
    J Korean Med Sci; 2002 Dec; 17(6):801-5. PubMed ID: 12483005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene in hepatocellular carcinomas from Australia.
    Vesey DA; Hayward NK; Cooksley WG
    Cancer Detect Prev; 1994; 18(2):123-30. PubMed ID: 8025894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.
    Honda K; Sbisà E; Tullo A; Papeo PA; Saccone C; Poole S; Pignatelli M; Mitry RR; Ding S; Isla A; Davies A; Habib NA
    Br J Cancer; 1998 Mar; 77(5):776-82. PubMed ID: 9514057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis.
    Vautier G; Bomford AB; Portmann BC; Metivier E; Williams R; Ryder SD
    Gastroenterology; 1999 Jul; 117(1):154-60. PubMed ID: 10381922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.